Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

SeraCare™ ACCURUN™ 644 Cystic Fibrosis 40plus4 Control

A synthetic, multiplex control formulated for research use in laboratory testing, molecular screening, and mutation testing

Manufacturer:  SeraCare™ 20400015

Catalog No. 22-554-478


Add to cart

Description

Description

  • Identifies mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene
  • Covers all 47 mutations in the Prima xTAG™ CFTR IVD Assay
  • Eliminate errors arising from use of rotating gDNA control schemes with incomplete mutation profiles
  • Controls contain a mixture of oligonucleotides that produce a call for every mutation tested
  • All mutations contained in a single vial
  • High purity, large lots, stable materials–no additional processing required

Not for use in diagnostic procedures

Specifications

Specifications

ACCURUN™ 644 Cystic Fibrosis 40+4 Control
CE, RUO
100μL
Detects significant errors with the use of rotating gDNA control schemes, research use only
Documents
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit